Evidence map›Paper›PMID 28698272›Full record

ArticlemBio2017

Sarah B Namugenyi, Alisha M Aagesen, Sarah R Elliott, Anna D Tischler

Open access · goldAbstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Reactive Oxygen Detoxification Contributes tobioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Bacterial persisters: molecular mechanisms and therapeutic development.Signal transduction and targeted therapy · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Phenotypic adaptation ofFrontiers in cellular and infection microbiology · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sarah B NamugenyiDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
Alisha M AagesenDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
Sarah R ElliottDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
Anna D TischlerDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA tischler@umn.edu.ORCID 0000-0001-8404-0250
University of Minnesota · US

Funding

Minnesota Craniofacial Research Training ProgramT90DE022732 · NIDCR · UNIVERSITY OF MINNESOTA · PI MANSKY, KIM CARPENTER · 2012 to 2023
$4.9M
High-Throughput Identification of Mycobacterium tuberculosis Persistence MechanisDP2AI112245 · NIAID · UNIVERSITY OF MINNESOTA · PI TISCHLER, ANNA DEGRAFF · 2013 to 2013
$2.2M
NIAID NIH HHS DP2 AI112245NIDCR NIH HHS T90 DE022732
6 · The paper itself

Abstract

The

Indexed as

AnimalsATP-Binding Cassette TransportersBacterial ProteinsGene Expression Regulation, BacterialMembrane Transport ProteinsMiceMycobacterium tuberculosisPhosphatesPhosphotransferasesRifampinSequence DeletionSignal TransductionTuberculosisATP-Binding Cassette TransportersBacterial ProteinsMembrane Transport ProteinsPhosphatesphosphate-specific transport protein A, bacteriaPhosphotransferasesRegX3 protein, MycobacteriumRifampinSenX3 protein, Mycobacteriumantibiotic toleranceMycobacterium tuberculosispersisterphosphatePhoUPst systemRegX3rifampin

Identifiers

PMID28698272
PMCPMC5513712
OpenAlexW2735773016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.